Press release
Outlook on the Compounding Chemotherapy Market: Major Segments, Strategic Developments, and Leading Companies
Compounding Chemotherapy Market
Anticipated Growth Trajectory of the Compounding Chemotherapy Market
The size of the compounding chemotherapy market is projected to reach $8.2 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.0%. This upward trend is supported by several key factors, including the development of automated and robotic compounding systems designed to improve precision and safety. Additionally, the expansion of homecare chemotherapy services and increased investments in sterile pharmacy infrastructure contribute significantly to this growth. The market is also benefiting from stricter regulatory requirements surrounding personalized medicine, as well as increased use of targeted therapies and immunomodulatory agents. Prominent trends expected to shape the landscape include the rising uptake of personalized chemotherapy formulations, integration of robotics in compounding, growth of specialty clinics and homecare settings, a stronger emphasis on sterile environments, and greater demand for supportive care drug compounding.
Download a free sample of the compounding chemotherapy market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25724&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR
Key Contributors to the Compounding Chemotherapy Market
Several leading companies play a pivotal role in this market, including Baxter International Inc., Fresenius Kabi AG, Option Care Health Inc., ICU Medical Inc., Fagron NV, BioScrip Inc., B. Braun Melsungen AG, Medisca Pharmaceutique Inc., Central Admixture Pharmacy Services Inc., Icon Group Holdings Pty Ltd, Avella Specialty Pharmacy, McGuff Compounding Pharmacy Services Inc., Epicur Pharma LLC, and PharMEDium Services LLC. These organizations continue to innovate and expand their capabilities to meet the growing needs of personalized chemotherapy compounding.
Significant Acquisition Enhancing Market Capabilities
In a strategic move to bolster growth, H.I.G. Capital LLC, a US-based investment firm, acquired ITH Group Limited in June 2025 for $70 million. ITH Group Limited, based in the UK, specializes in aseptic compounding services, including chemotherapy preparation. This acquisition aims to support ITH Group's organic growth, increase production capacity, and advance its digital pharmacy services, ultimately strengthening its position in the market.
View the full compounding chemotherapy market report:
https://www.thebusinessresearchcompany.com/report/compounding-chemotherapy-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR
Innovations Steering the Future of Compounding Chemotherapy
Market leaders are prioritizing the development of cutting-edge solutions like robotic chemotherapy automation systems to boost accuracy, safety, and efficiency in preparing personalized cancer treatments. These sophisticated machines automate the compounding process, substantially reducing human error and minimizing contamination risks. For example, in February 2024, Israeli healthcare tech firm Simplivia Healthcare Ltd. introduced its Smart Compounders Advanced Systems. These systems automate the preparation of cytotoxic drugs and antibodies, capable of producing 20 to 40 preparations per hour. They feature automatic gravimetric verification and documentation to ensure precision, protect pharmacy staff from hazardous exposure, and are designed for seamless integration into existing laminar airflow cabinets or isolators without requiring structural modifications.
Comprehensive Segmentation of the Global Compounding Chemotherapy Market
This market is analyzed across various dimensions, including:
1) Drug Type: Cytotoxic Drugs, Hormonal Agents, Immunomodulatory Agents, Targeted Therapies, Supportive Care Drugs
2) Route of Administration: Intravenous, Oral, Subcutaneous, Intramuscular, Intrathecal
3) Technology: With Robotic Arms, Without Robotic Arms
4) Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) Compounding Setting: Hospital Compounding, Compounding Pharmacies, Specialty Clinics, Homecare Settings
Further breakdown under Drug Type includes:
- Cytotoxic Drugs: Alkylating Agents, Antimetabolites, Plant Alkaloids, Antitumor Antibiotics, Topoisomerase Inhibitors
- Hormonal Agents: Estrogen Antagonists, Androgen Deprivation Therapy Agents, Aromatase Inhibitors, Progestins, Gonadotropin-Releasing Hormone Agonists
- Immunomodulatory Agents: Immune Checkpoint Inhibitors, Monoclonal Antibodies, Interleukins, Cytokines, Immune System Activators
- Targeted Therapies: Tyrosine Kinase Inhibitors, Proteasome Inhibitors, Mammalian Target of Rapamycin Inhibitors, Poly Polymerase Inhibitors
- Supportive Care Drugs: Antiemetics, Erythropoiesis-Stimulating Agents, Bone-Modifying Agents, Pain Management Drugs
This detailed segmentation provides a clear framework to understand the evolving market dynamics and growth opportunities within the compounding chemotherapy space.
What's new in our 2026 market reports:
• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel dashboards
• Market hotspots infographics
• Key technologies and future trends
• Updated graphics and tables
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Outlook on the Compounding Chemotherapy Market: Major Segments, Strategic Developments, and Leading Companies here
News-ID: 4592650 • Views: …
More Releases from The Business Research Company
Death Care Services Market Demonstrates Long-Term Growth Potential At 7.9% CAGR
The death care services market is on track for significant expansion, reflecting changing consumer preferences and evolving industry practices. With growing interest in personalized and eco-friendly options, the sector is experiencing notable transformation. Let's explore the market size projections, key players, emerging trends, and segmentation to understand the future direction of this important industry.
Projected Growth and Market Size of the Death Care Services Industry
The death care services market…
Cyanoacrylate Adhesives Market Outlook Signals Expansion To $2.1 Billion Through …
The cyanoacrylate adhesives market is set for significant expansion over the coming years, driven by increasing demand for high-performance bonding solutions across various industries. This segment is evolving rapidly due to technological advancements and growing adoption in precision assembly and lightweight jointing applications. Let's explore the market size projections, key players, emerging trends, and segmentation details shaping this dynamic industry.
Long-Term Outlook for the Cyanoacrylate Adhesives Market Size Through 2030 …
Crowdfunding Market Report 2026 Market Outlook Supported By A Forecast 17.1% CAG …
The crowdfunding sector is gaining significant traction as more startups and investors embrace alternative financing methods. With the rise of innovative funding platforms and increasing regulatory support, this market is set for remarkable growth in the coming years. Here's a detailed overview of the market's size, key players, emerging trends, and segment breakdown.
Projected Market Value and Growth Trajectory of the Crowdfunding Market
The crowdfunding market is anticipated to expand…
Credentials Verification Organization (CVO) Services Market Insights Highlight S …
The credentials verification organization (CVO) services sector is on the cusp of remarkable expansion, driven by technological advancements and evolving market needs. As organizations increasingly prioritize secure and efficient verification methods, this industry offers promising growth prospects. Here's an in-depth look at the market size, key players, emerging trends, and segment analysis shaping the future of CVO services.
Projected Market Value Surge in Credentials Verification Organization (CVO) Services
The credentials…
More Releases for Compounding
Compounding Pharmacies Business Development Strategies for Expanding Your Market …
The global compounding pharmacies market size was US$ 8.1 billion in 2021. The global compounding pharmacies market size is estimated to reach US$ 13.9 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.2% during the forecast period from 2022 to 2030.
Request To Download Sample of This Strategic Report :-https://reportocean.com/industry-verticals/sample-request?report_id=bwcc17220
A compounding pharmacy is a distinctive kind of pharmacy. They can create customized medicines for the individual who…
NBR Compounding Market Report Status And Outlook 2022-2027-Hexpol Compounding, P …
The NBR Compounding Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. We analyzed the impact of…
Global Compounding Pharmacies Market, Global Compounding Pharmacies Industry, Co …
The Compounding Pharmacies market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The Global Compounding Pharmacies Market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Compounding Pharmacies market. The report focuses on well-known providers in the global…
U.S. Compounding Pharmacies Market Global Key Players - Premier Pharmacy Labs, R …
Endowed with numerous regulatory compliances, the U.S. compounding pharmacies market has been traversing toward becoming one of the most profitable business spaces. Owing to the lack of safety and absence of clinical clearances, compounded medications have been under stringent scrutiny that has been helping players in the U.S. compounding pharmacies to strengthen their existing manufacturing practices. The surging use of compounded medicines for pain relief and hormone replacement therapies is…
U.S. Compounding Pharmacies Market ; Eminent Players - Pencol Compounding Pharma …
Endowed with numerous regulatory compliances, the U.S. compounding pharmacies market has been traversing toward becoming one of the most profitable business spaces. Owing to the lack of safety and absence of clinical clearances, compounded medications have been under stringent scrutiny that has been helping players in the U.S. compounding pharmacies to strengthen their existing manufacturing practices. The surging use of compounded medicines for pain relief and hormone replacement therapies is…
U.S. Compounding Pharmacies Market Key Players – McKesson Corporation, Nephron …
U.S. Compounding Pharmacies Market size is set to exceed USD 7 billion by 2025; according to a new research report by Global Market Insights, Inc.
Growing prevalence of chronic diseases in the U.S. such as cancer, diabetes, cardiovascular disease, respiratory diseases and obesity will drive the U.S. compounding pharmacies market growth over the forecast period. Increasing drug shortage in the country due to production delays and unavailability of previously manufactured…
